Quinolino-pyrrolidin-2-one derivative and application thereof
AssigneeMedshine Discovery Inc.
InventorsWenyuan Qian, Chundao Yang, Guoqiang Dai, Jian Li, Shuhui Chen
Life of this patent
Estimating the term…
Abstract
Disclosed are a series of quinolino-pyrrolidin-2-one compounds, and application thereof in preparation of drugs for ATM inhibitor-related diseases. The present disclosure specifically relates to a derivative compound represented by formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.
Claims22
A compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof,
- wherein,
- E is selected from —N(R5)—, —O— and —C(R6)(R7)—;
- R1 is selected from C1-3 alkyl, C1-3 alkoxy and C3-6 cycloalkyl, wherein the C1-3 alkyl, C1-3 alkoxy and C3-6 cycloalkyl are optionally substituted with 1, 2 or 3 Ra;
- R2 is selected from H, F, Cl, Br, I, OH and NH2;
- R3 is selected from H, F, Cl, Br, I, OH, NH2, CN, C1-3 alkyl and C1-3 alkoxy, wherein the C1-3 alkyl and C1-3 alkoxy are optionally substituted with 1, 2 or 3 Rb;
- R4 is selected from C1-6 alkyl and N(Rc)(Rd);
- R5 is selected from H, C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkyl-C═O—, C1-6 alkyl-O—C═O— and C3-6 cycloalkyl-C═O—, wherein the C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkyl-C═O—, C1-6 alkyl-O—C═O— and C3-6 cycloalkyl-C═O— are optionally substituted with 1, 2 or 3 Re;
- R6 and R7 are each independently selected from H, F, Cl, Br, I, OH, NH2, CN, C1-6 alkyl and C1-6 alkoxy, wherein the C1-6 alkyl or C1-6 alkoxy are optionally substituted with 1, 2 or 3 Rf;
- L1 is selected from a single bond, —(CH2)m— and —(CH2)m—O—;
- m is selected from 1, 2, 3 and 4;
- ring B is selected from phenyl and 5- to 6-membered heteroaryl, wherein the phenyl and 5-to 6-membered heteroaryl are optionally substituted with 1, 2 or 3 Rg;
- Ra and Rb are each independently selected from F, Cl, Br, I, OH and NH2;
- Rc and Rd are each independently selected from H, C1-3 alkyl and C3-6 cycloalkyl, wherein the C1-3 alkyl and C3-6 cycloalkyl are each independently selected from 1, 2 or 3 R;
- or, Rc and Rd together with the N atom to which they are attached form 4- to 6-membered heterocycloalkyl optionally substituted by 1, 2 or 3 R;
- Re, Rf and Rg are each independently selected from F, Cl, Br, I, OH and NH2;
- Each R is independently selected from F, Cl, Br, I, OH and NH2;
- and the 5- to 6-membered heteroaryl and 4- to 6-membered heterocycloalkyl are each independently comprise 1, 2, 3 or 4 heteroatoms or heteroatom groups independently selected from —NH—, —O—, —S— and N.
A compound represented by the following formulas, an isomer thereof or a pharmaceutically acceptable salt thereof, wherein the compound is selected from
Dependencies are inferred from the claim text.